Another edition of Interphex NY has ended up in a convincing demonstration of how IMA Life stays on the "crest of innovation" with its latest technology for aseptic filling, introducing a modular, fully gloveless system based on magnetic levitation.
The Automated Plate Seal Remover from Azenta Life Sciences is a compact system for removing seals from a wide range of microplates at the single touch of a button, without damaging the plate or seal.
Broughton, a analytical testing and consultancy firm, highlights its commitment to sustainability in laboratory operations by promoting environmentally responsible practices, ethical governance, and proactive maintenance strategies.
Following the first virtual presentation at Interphex, Syntegon is now introducing its new filling machine for ready-to-use (RTU) nested syringes to the market.
ArisGlobal has announced that another pharmaceutical company has chosen LifeSphere Advanced Signals, a pharmacovigilance solution that leverages automation and AI-driven insights to streamline signal detection and management.
Phastar, a specialist biometrics & data science Contract Research Organisation (CRO), has been shortlisted in the ‘CRO Partnership of the Year’ category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health.
Berry Global Healthcare to showcase latest technologies for patient-centric solutions participation at this year’s RDD (Respiratory Drug Delivery) Europe Conference, taking place at the Estoril Congress Centre, Portugal from 6-9 May.
Teckro has introduced its new Patient Data Return feature, providing patients with seamless access to their medical reports while giving sponsors greater oversight into engagement levels.
Ellie Gabel, Associate Editor for Revolutionized explains how cleaning and sterilisation are essential but often unoptimised processes within pharmaceutical facilities.
Infinitopes has announced that the UK Medicines and Healthcare products Regulatory Agency has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company’s ‘off-the-shelf’ cancer vaccine.
